tiprankstipranks
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
US Market
NAUT
Nautilus Biotechnolgy
RESEARCH TOOLSreports
Want to see NAUT full AI Analyst Report?

Nautilus Biotechnolgy (NAUT) Income Statement

182 Followers

Nautilus Biotechnolgy Income Statement

Last quarter (Q1 2026), Nautilus Biotechnolgy's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Nautilus Biotechnolgy's net income was $-14.70M. See Nautilus Biotechnolgy’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -6.46M$ -6.35M$ -5.71M$ -3.42M$ -2.84M
Operating Expenses
$ 60.37M$ 75.12M$ 70.45M$ 60.20M$ 47.66M
Depreciation and Amortization
$ 6.46M$ 6.35M$ 1.85M$ 3.42M$ 2.84M
EBITDA
$ -52.54M$ -64.43M$ -74.30M$ -54.51M$ -47.47M
Operating Income
$ -66.84M$ -81.48M$ -76.15M$ -63.62M$ -50.50M
Other Income/Expenses
$ 7.84M$ 10.70M$ 12.48M$ 5.69M$ 183.00K
Pretax Income
$ -59.00M$ -70.78M$ -63.67M$ -57.92M$ -50.31M
Net Income
$ -59.00M$ -70.78M$ -63.67M$ -57.92M$ -50.31M
Per Share Metrics
Basic EPS
$ -0.47$ -0.56$ -0.51$ -0.46$ -0.60
Diluted EPS
$ -0.47$ -0.56$ -0.51$ -0.46$ -0.60
Weighted Average Shares Outstanding
 126.26M 125.43M 124.92M 124.59M 84.46M
Weighted Average Shares Outstanding (Diluted)
 126.26M 125.43M 124.92M 124.59M 84.46M
Currency in USD

Nautilus Biotechnolgy Earnings and Revenue History